ArticleCase reports in oncology

Durable Response to Pazopanib in a Patient with Fumarate Hydratase-Mutant Tubulocystic Renal Cell Carcinoma.

Anjum Othman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.